Related Experiment Video
Updated: Mar 7, 2026
06:09
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
23.0K
Cross-talk between LRRK2 and PKA: implication for Parkinson's disease?
Elisa Greggio1, Luigi Bubacco2, Isabella Russo2
1Department of Biology, University of Padova, Via Ugo Bassi 58/B, Padova 35121, Italy elisa.greggio@unipd.it isabella.russo@unipd.it.
Biochemical Society Transactions
|February 17, 2017
Summary
Leucine-rich repeat kinase 2 (LRRK2) and Protein Kinase A (PKA) signaling are vital in brain function and Parkinson's disease (PD). This review explores their interconnected roles in neurons and microglia.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Leucine-rich repeat kinase 2 (LRRK2) regulates neuronal and glial cell functions.
- Mutations in LRRK2 are the most common cause of autosomal dominant Parkinson's disease (PD).
- Protein Kinase A (PKA) signaling is crucial for brain homeostasis, neuronal development, and inflammation control.
Purpose of the Study:
- To review the evidence linking PKA and LRRK2 in neuronal and microglial functions.
- To provide an overview of the cross-talk between PKA and LRRK2.
- To discuss the molecular and cellular implications of this interaction.
Main Methods:
- Literature review of existing research on LRRK2 and PKA signaling.
- Analysis of studies investigating the roles of LRRK2 and PKA in neurodegeneration.
- Synthesis of findings on the interplay between these kinases.
Main Results:
- LRRK2 and PKA signaling pathways are implicated in neuron and microglia functions.
- Dysregulation of LRRK2 is linked to Parkinson's disease.
- Declining PKA signaling contributes to neurodegenerative disease progression.
Conclusions:
- There is accumulating evidence for a link between PKA and LRRK2 in brain cells.
- The cross-talk between PKA and LRRK2 has significant molecular and cellular implications for brain function and disease.
- Further research is needed to fully elucidate the complex interactions between these kinases in health and Parkinson's disease.
Related Concept Videos
01:15Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
01:22Lysosomal Hydrolases
4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
01:37Neural Regulation
43.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.9K
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:19Interactions Between Signaling Pathways
7.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
01:22PI3K/mTOR/AKT Signaling Pathway
6.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.0K